Table 1 Clinical baseline characteristics compared with mean and peak leptin sample
Variables | Mean Leptin | Peak Leptin | |||
|---|---|---|---|---|---|
| Â | Normoleptinemia | hyperleptinemia | Normoleptinemia | hyperleptinemia | |
|  | N = 13 (29.5%) | N = 31 (70.4%) | N = 5 (13.1%) | N = 33 (86.8%) | |
Sex | Male | 11(84.6%) | 31(100.0%) | 4(80.0%) | 32 (97.0%) |
Female | 2(15.4%) | 0(0.0) | 1(20.0%) | 1(3.0%) | |
Age group | ≤50 years | 7(53.8%) | 17(54.8%) | 2(40.0%) | 17 (51.5%) |
>50 years | 6(46.2%) | 14(45.2%) | 3(60.0%) | 16 (48.5%) | |
Diabetic | Yes | 8(61.5%) | 9(29.0%) | 5(100.0%) | 10 (30.3%) |
No | 5(38.5%) | 22(71.0%) | 0(0.0) | 23 (69.7%) | |
Hypertensive | Yes | 4(30.8%) | 5(16.1%) | 1(20.0%) | 6(18.2%) |
No | 9(69.2%) | 26(83.9%) | 4(80.0%) | 27(81.8 %) | |
Body mass index (Kg/m2) | <25 | 5(45.5%) | 2(6.9%) | 2(40.0%) | 3(10.0%) |
25-30 | 4(36.4%) | 19(65.5%) | 3(60.0%) | 18(60.0%) | |
>30 | 2(18.2%) | 8(27.6%) | 0(0.0) | 9(30.0%) | |
High Cholesterol >5.2 mmol/l | Yes | 5(38.5%) | 4(12.9%) | 1(20.0%) | 7(21.2%) |
| Â | No | 8(61.5%) | 27(87.1%) | 4(80.0%) | 26(78.8%) |
HDL* | Abnormal (<1)mmolL | 10(90.9%) | 10(37.0%) | 5(100.0%) | 12(41.4%) |
Normal(>1) mmol/L | 1(9.1%) | 17(63.0%) | 0(0.0) | 17(58.6%) | |
LDL | ≤3.3 mmol/L | 4(40.0%) | 20(69.0%) | 3(75.0%) | 19(61.3%) |
>3.3 mmol/L | 6(60.0%) | 9(31.0%) | 1(25.0%) | 12(38.7%) | |
Triglyceride | ≤1.7 mmol/L | 6(66.7%) | 7(24.1%) | 1(25.0%) | 11(35.5%) |
>1.7 mmol/L | 3(33.3%) | 22(75.9%) | 3(75.0%) | 20(64.5%) | |
MI type | Anterior | 8(66.7%) | 19(61.3%) | 4(80.0%) | 19(59.4%) |
Inferior | 4(33.3%) | 10(32.3%) | 1(20.0%) | 11(34.4%) | |
| Â | Non ST Elevation | 0(0.0) | 2(6.5%) | 0(0.0) | 2(6.3%) |